All News

Q: Is the treatment for Osteoporosis different for males than females? I am a 67 year old male. Recently by x-rays of my back, it was stated in the report that I have osteoporosis . In a phone conversation with my primary physician's assistant, he stated that I should be on hormones, but that he would have to run it by the primary physician. Since that time, and this was at thanksgiving, I have tried to make contact, by phone to the primary physician. I was told, by office personnel, that I should make an appointment to discuss the situation. My question is, why is it necessary to discuss treatment face to face? Can't he advise me by phone? What is necessary? My schedule is very irregular and also why the extra expense for an office visit just to say here is what you do and if a prescription is necessary, can't he call it in as has been done on other occasions. I would like to know also, isn't it rather uncommon for a male to have this condition? Could you tell me what is the usual treatment in this kind of situation?

A prospective study involving a cohort of over 100,000 female registered nurses from the Nurses' Health Study II finds that women who are infertile due to ovulatory disorders are about 25% less likely to develop breast cancer than women who report no fertility problems (covariate-adjusted hazard ratio 0.75; 95% CI, 0.59-0.96).

With as many as 9 out of 10 menstruating women reporting some premenstrual moody blues, what criteria do you use to differentiate mild PMS from severe PMS from premenstrual dysphoric disorder? And what treatments are effective?

Women who smoke cigarettes and who are infected with high levels of human papillomavirus type 16 (HPV-16) increase their risk of cervical cancer as much as 27-fold, according to a Swedish study, which is one of the largest to date on the subject.

Adding the anthracycline epirubicin to cyclophosphamide, methotrexate, and fluorouracil (CMF) is superior to CMF alone as adjuvant therapy for early breast cancer, regardless of estrogen-receptor status, tumor grade, or patient age.

Reducing dietary fat intake by about 35% reduced the risk of a relapse event in women with resected, early-stage breast cancer receiving conventional cancer management by about 24%, according to interim efficacy results from the Women's Intervention Nutrition Study, the first large-scale randomized trial to test whether a dietary intervention can improve outcome in women with breast cancer.

More than 1 year of therapy with proton pump inhibitors (PPIs) increases the risk of hip fracture by about 40%, according to results from a nested case–control study conducted by researchers at the University of Pennsylvania.

Women who receive higher amounts of daily magnesium, either from their diet or supplements, have a modestly lower risk for hypertension, according to a report in the December issue of the American Journal of Cardiology.

Children born to women who take fish oil supplements during late pregnancy have better eye/hand coordination at age 2 to 3 years than their counterparts whose mothers did not take the supplements, according to a study published online Dec. 21 in the Archives of Disease in Childhood-Fetal and Neonatal Edition.

Questions this month have been answered by:Simon Kipersztok, MD, OBGYN.net Osteoporosis Editorial Advisor Alice Rhoton-Vlasak, MD, OBGYN.net Osteoporosis Editorial Advisor Barry L. Gruber, MD, OBGYN.net Osteoporosis Editorial Advisor